MedKoo Cat#: 206751 | Name: CE-245677
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

CE-245677 is a selective, orally active Tie2 kinase inhibitor identified by Pfizer previously in development for the treatment of certain cancers. CE-245,677 is a potent reversible inhibitor of Tie2 and TrkA/B kinases with a cellular IC50 of 4.7 and 1 nM, resp., displays >100x selectivity against a number of other angiogenic receptor tyrosine kinases (e.g. KDR, PDGFR, FGFR) and gene family panels, and demonstrates good oral absorption in in vivo rat PK studies (F=80%).

Chemical Structure

CE-245677
CE-245677
CAS#717899-97-3 (free base)

Theoretical Analysis

MedKoo Cat#: 206751

Name: CE-245677

CAS#: 717899-97-3 (free base)

Chemical Formula: C24H22Cl2N6O3

Exact Mass: 512.1130

Molecular Weight: 513.38

Elemental Analysis: C, 56.15; H, 4.32; Cl, 13.81; N, 16.37; O, 9.35

Price and Availability

Size Price Availability Quantity
25mg USD 250.00 2 Weeks
50mg USD 450.00 2 Weeks
100mg USD 750.00 2 Weeks
200mg USD 1,250.00 2 Weeks
500mg USD 2,750.00 2 Weeks
1g USD 3,750.00 2 Weeks
2g USD 6,450.00 2 Weeks
Show More
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
941588-94-9 (mesylate) 717899-97-3 (free base) 941588-98-3 (tosylate) 941588-96-1 (besylate)
Synonym
CE-245677; CE 245677; CE245677; CE-245,677; CE 245,677; CE245,677
IUPAC/Chemical Name
1-(5-(4-amino-7-isopropyl-7H-pyrrolo[2,3-d]-pyrimidine-5-carbonyl)-2-methoxyphenyl)-3-(2,4-dichlorophenyl)urea
InChi Key
VFCRSIORGUNNGT-UHFFFAOYSA-N
InChi Code
InChI=1S/C24H22Cl2N6O3/c1-12(2)32-10-15(20-22(27)28-11-29-23(20)32)21(33)13-4-7-19(35-3)18(8-13)31-24(34)30-17-6-5-14(25)9-16(17)26/h4-12H,1-3H3,(H2,27,28,29)(H2,30,31,34)
SMILES Code
O=C(NC1=CC=C(Cl)C=C1Cl)NC2=CC(C(C3=CN(C(C)C)C4=NC=NC(N)=C43)=O)=CC=C2OC
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Phase I multiple dose trials were stopped due to the development of significant CNS adverse events which included cognitive deficits, personality changes, and sleep disturbances. Related CAS# 717899-97-3 (CE-245677 free base) 941588-92-7 (CE-245677 phosphate) 941588-94-9 (CE-245677 sulfate) 941588-96-1 (CE-245677 besylate) 941588-98-3 (CE-245677 tosylate)
Product Data
Solvent mg/mL mM
Solubility
DMSO 125.0 243.48
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 513.38 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
http://cancerres.aacrjournals.org/content/67/9_Supplement/3259 Identification of selective, orally active Tie2 kinase inhibitors and discovery of CE-245,677 and PF-371,989 Susan LaGreca, Joel Arcari, Deborah Baker, Gary Borzillo, Jinshan Chen, Tracey Clark, Bruce Cohen, William Hungerford, Shefali Kakar, Aaron Kanter, Elisabeth Knauth, Yong Lu, Luis Martinez-Alsina, Matthew Marx, Nandini Patel, Catherine Soderstrom, George Tkalcevic, Carl Thompson, Merin Troutman, Patrick Vincent and Matthew Wessel AACR Annual Meeting-- Apr 14-18, 2007; Los Angeles, CA Published 1 May 2007